Lv1
44 积分 2025-06-09 加入
Cholesterol's new tricks propel MASH-HCC: impact in immunotherapy
3天前
已完结
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion
19天前
已完结
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-Analysis
1个月前
已完结
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
1个月前
已完结
Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma
1个月前
已完结
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
1个月前
已完结
New advances in the diagnosis and management of hepatocellular carcinoma
2个月前
已完结
KLF9 drives intermittent hypoxia-induced MASLD by suppressing the NR4A1–p38 MAPK hepatic metabolic axis
2个月前
已完结
Chiral Single‐Atom Nanozymes‐Enabled ROS Catalysis and Metal Transport Regulation Cooperatively Induce Ferroptosis to Treat Bacterial Infections
2个月前
已完结
Multiscale identification of DNASE1L3 as a key target in MASLD progression to hepatocellular carcinoma
3个月前
已完结
皖公网安备34019202002308
